Reny Haryani
Institut Teknologi Sumatera

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

Evaluasi resep obat batuk anak di salah satu apotek Reny Haryani; Lailatul Kasanah; Rastria Meilanda
THE JOURNAL OF Mother and Child Health  Concerns Vol. 4 No. 7 (2025): October Edition
Publisher : Indonesian Public Health-Observer Information Forum (IPHORR) Kerjasama dengan Persatuan Perawat Nasional Indonesia (PPNI)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.56922/mchc.v4i6.1601

Abstract

Background: Prescription review is an evaluation of prescription writing conducted by pharmaceutical personnel, covering administrative, pharmaceutical, and clinical aspects. Prescription review is an important step in preventing medication errors. Purpose: to determine the appropriateness of prescriptions for children's cough medicine. Method: This study used a non-experimental design with a descriptive approach. The sampling technique was simple random sampling. Based on calculations using the Slovin formula, 96 prescriptions were obtained, which were then rounded up to 100 prescriptions as the research sample. Results: The study showed the completeness of administrative aspects included: patient name (100%), age (100%), gender (0%), weight (0%), doctor's name (100%), and doctor's SIP number (51%). In the pharmaceutical aspect, the results obtained were dosage strength (1%), route of administration (100%), and drug combination suitability (100%). Meanwhile, in the clinical aspect, the results were: drug interaction suitability (94%), drug dosage (88%), drug administration route and allergy history (100%), and contraindications (100%). Conclusion: Prescriptions for children's cough medicine for the period January–December 2022 generally complied with the standards set out in Regulation of the Minister of Health of the Republic of Indonesia Number 73 of 2016.
Effectiveness and safety of oral versus intravenous iron therapy in iron deficiency anemia during pregnancy: A pharmacological review Reny Haryani; Juwana Janu
THE JOURNAL OF Mother and Child Health  Concerns Vol. 5 No. 1 (2026): April Edition 2026
Publisher : Indonesian Public Health-Observer Information Forum (IPHORR) Kerjasama dengan Persatuan Perawat Nasional Indonesia (PPNI)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.56922/mchc.v5i1.3058

Abstract

Background: Iron deficiency anemia is a global health problem commonly occurring during pregnancy. The World Health Organization reported a prevalence of 35.5% in 2023, which may lead to serious consequences for both mother and fetus. Management of this condition is generally carried out through oral or intravenous iron therapy, each having its own advantages and limitations. Purpose: to evaluate the effectiveness and safety of oral versus intravenous iron therapy in pregnant women with iron deficiency anemia. Method: A limited systematic review was conducted based on PRISMA guidelines. Literature searching was performed using the PubMed database for studies published between 2015 and 2025. A total of 75 articles were identified, of which 5 studies met the inclusion criteria and were analyzed descriptively. Results: The findings showed that intravenous iron therapy, particularly ferric carboxymaltose, was more effective in increasing hemoglobin and ferritin levels compared to oral therapy. In terms of safety, oral iron was more frequently associated with gastrointestinal side effects, whereas intravenous iron was generally well tolerated with mild adverse effects. Conclusion: Intravenous iron therapy demonstrates superior effectiveness in improving hematological parameters; however, oral iron remains the first-line therapy due to its accessibility and lower cost. Therefore, treatment selection should be individualized based on the patient’s clinical condition.